JUN 24, 2021 8:00 AM PDT

Should We Rethink COVID Vaccine Recipes?

WRITTEN BY: Tara Fernandez

In a study reported in the journal Cell, immunologists provide evidence for an Achilles’ heel in current COVID-19 vaccines: they don’t harness the full potential of the immune system. Commercially-available COVID vaccines work by triggering B cells, immune cells responsible for the generation of virus-specific antibodies.

However, vaccines capable of simultaneously activating T cells have the potential to bolster immunity against SARS-CoV-2 and critically, the rapidly emerging viral variants. Now, researchers have identified a panel of SARS-CoV-2 viral peptides capable of eliciting powerful and potentially life-saving T cell-mediated immune responses.

According to Boston University’s Mohsan Saeed, one of the study authors, based on this new data, “companies should reevaluate their vaccine designs.”

Saeed teamed up with computational geneticists to identify SARS-CoV-2 fragments capable of mounting a robust protective T cell response. Cells in the body infected with viruses “chop up” viral proteins into tiny fragments that are presented on the surface of cells to alert T cells to the pathogenic intruder. Once the alarm is raised, T cells launch an all-out attack on infected cells, eliminating them and halting the progression of the infection. In the case of COVID-19, the stronger these T cell responses are, the less likely it is that patients will go on to develop severe, life-threatening symptoms.

Importantly, once T cells are primed, they “remember” the coronavirus’ fragments, setting off a much stronger and faster immune attack the next time it encounters the virus or its variants. This is a particularly advantageous feature in the context of COVID infections, as the researchers say that these are often associated with a lag in immune cell recruitment.

“This virus wants to go undetected by the immune system for as long as possible,” Saeed says. “Once it’s noticed by the immune system, it’s going to be eliminated, and it doesn’t want that.”

Saeed and colleagues say the protein fragments the team discovered could be used for novel vaccine recipes that are capable of shielding against the ever-growing number of coronavirus variants. Such a variant-resistant COVID vaccine would be a powerful weapon in our fight against the virus.

 

Sources: Cell, Boston University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
MAY 06, 2021
Immunology
COVID Vaccines Don't Protect Everyone
MAY 06, 2021
COVID Vaccines Don't Protect Everyone
New research has revealed that COVID-19 vaccines may not work as effectively in those whose immune systems have been neg ...
MAY 13, 2021
Immunology
Tumors Hide From the Immune System by Masquerading as Baby Cells
MAY 13, 2021
Tumors Hide From the Immune System by Masquerading as Baby Cells
The immune system is programmed to recognize foreign bodies as potentially dangerous, promptly removing them before the ...
JUN 17, 2021
Immunology
How T Cells Sense Dangerous Invaders
JUN 17, 2021
How T Cells Sense Dangerous Invaders
T cells form a major part of our immune defenses, protecting us against the constant barrage of potentially pathogenic p ...
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
JUL 30, 2021
Cancer
Obesity Reduces Mortality in Advanced Prostate Cancer
JUL 30, 2021
Obesity Reduces Mortality in Advanced Prostate Cancer
Obese patients with an advanced form of prostate cancer survive longer than their slimmer counterparts, according to res ...
Loading Comments...